A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 5892-5902

  Aparicio, Isabela M ^a   Scharfstein, Julio ^a   Lima, Ana Paula C A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CRUZIPAIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; KININ; KININ RECEPTOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; N METHYLPIPERAZINEUREAPHENYLALANYLHOMOPHENYLALANINE VINYLSULFONE BENZENE; PROTEINASE; RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CARDIOMYOPATHY; CELL INVASION; CHAGAS DISEASE; EPIMASTIGOTE; GASTROINTESTINAL DISEASE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; SUPERNATANT; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALS; CELL LINE; CELLS; CHAGAS DISEASE; CRICETINAE; CYSTEINE ENDOPEPTIDASES; HUMANS; MEMBRANES; MICE; RABBITS; TRYPANOSOMA CRUZI;

EID: 4644357065     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.5892-5902.2004     Document Type: Article

References (30)

1. 2+ signaling in mammalian cells. J. Biol. Chem. 136:609-620.
2. Burleigh, B. A., and A. M. Woolsey. 2002. Cell signaling and Trypanosoma cruzi invasion. Cell. Microbiol. 4:701-711.
3. Caler, E. V., S. Vaena de Avalos, P. A. Haynes, N. W. Andrews, and B. A. Burleigh. 1998. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 17:4975-4986.
4. Caler, E. V., S. Chakrabarti, K. T. Fowler, S. Rao, and N. W. Andrews. 2001. The exocytosis-regulatory protein synaptotagmin VII mediates cell invasion by Trypanosoma cruzi. J. Exp. Med. 193:1097-1104.
5. Campetella, O., J. Henriksson, L. Aslund, A. C. C. Frasch, U. Pettterson, and J. J. Cazzulo. 1992. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes. Mol. Biochem. Parasitol. 50:225-234.
6. Cazzulo, J. J., J. Martinez, and A. J. Parodi. 1992. On the posttranslational modifications at the C-terminal domain of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiol. Lett. 79:411-416.
7. Del Nery, E., M. A. Juliano, M. Meldal, I. Svendsen, J. Scharfstein, A. Walmsley, and L. Juliano. 1997. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. Biochem. J. 323:427-433.
8. 2+ signal induced by Trypanosoma cruzi metacyclic trypomastigote surface molecules implicated in mammalian cell invasion. Mol. Biochem. Parasitol. 73:285-289.
9. Eakin, A. E., R. R Mills, G. Harth, J. H McKerrow, and C. S. Craik. 1992. The sequence, genomic organization and expression of the major cysteine proteinase (cruzain) from Trypanosoma cruzi. J. Biol. Chem. 267:7411-7420.
10. Engel, J. C., P. S. Doyle, I. Hsieh, and J. H. McKerrow. 1998. Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188:725-734.
11. Gonçalves, M. F., E. S. Umezawa, A. M. Katzin, W. de Souza, M. J. Alves, B. Zingales, and W. Colli. 1991. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp. Parasitol. 72:43-53.
12. Grellier, P., S. Vendeville, R. Joyeau, I. M. D. Bastos, H. Drobecq, F. Frappier, A. R. L. Teixeira, J. Schével, E. Davioud-Charvet, C. Sergheraert, and J. M Santana. 2001. Trypanosoma cruzi prolyl-oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J. Biol. Chem. 276:47078-47086.
13. Harth, G., N. W. Andrews, A. A. Mills, J. C. Engel, R. Smith, and J. H. McKerrow. 1993. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Mol. Biochem. Parasitol. 58:17-24.
14. 3,) of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent-quenched peptides: a comparative study and identification of specific carboxy-peptidase activity. Biochem. J. 373:933-939.
15. Lima, A. P. C. A., D. C. Tessier, D. Y. Thomas, J. Scharfstein, and T. Vernet. 1994. Identification of new cysteine protease gene isoforms in Trypanosoma cruzi. Mol. Biochem. Parasitol. 67:333-338.
16. Lima, A. P. C. A., F. C. G. Reis, C. Serveau, G. Lalmanach, L. Juliano, R. Ménard, T. Vernet, D. Y. Thomas, A. C. Storer, and J. Scharfstein. 2001. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors. Mol. Biochem. Parasitol. 114:41-52.
17. Lima, A. P. C. A., P. C. Almeida. I. L. S. Tersariol, V. Schmitz, A. H. Schmaier, L. Juliano, I. Y. Hirata, W. Muller-Esterl, J. R. Chagas, and J. Scharfstein. 2002. Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain. J. Biol. Chem. 277:5875-5881.
18. McGrath, M. E., A. E. Eakin, J. C. Engel, J. H. McKerrow, C. S. Craik, and R. A Fletterick. 1995. The crystal structure of cruzain: a therapeutic target for Chagas' disease. J. Mol. Biol. 247:251-259.
19. Meirelles, M. N., L. Juliano, E. Carmona, S. G. Silva, E. M. Costa, A. C. Murta, and J. Scharfstein. 1992. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 52:175-184.
20. Miles, M. A., M. Yeo, and M. Gaunt. 2003. Genetic diversity of Trypanosoma cruzi and the epidemiology of Chagas disease, p. 1-15. In J. M. Kelly (ed.), Molecular pathogenesis of Chagas' disease. Landes Bioscience, Austin, Tex.
21. Monteiro, A. C. S., M. Abrahamson, A. P. C. A. Lima, M. A. Vannier-Santos, and J. Scharfstein. 2001. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J. Cell Sci. 114:3933-3942.
22. Murta, A. C., P. M. Persechini, T. Souto-Padron, W. de Souza, J. A. Guimarães, and J. Scharfstein. 1990. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase. Mol. Biochem. Parasitol. 43:27-38.
23. 2-receptors. J. Exp. Med. 192:1289-1299.
24. Scharsftein, J. 2003. Activation of bradykinin-receptors by Trypanosoma cruzi: a role for cruzipain in microvascular pathology, p. 111-137. In J. M. Kelly (ed.), Molecular pathogenesis of Chagas' disease. Landes Bioscience, Austin, Tex.
25. Tardieux. I., P. Webster, J. Ravesloot, W. Boron, J. A. Lunan, J. E. Heuser, and N. W. Andrews. 1992. Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 73:1117-1130.
26. 2+ transients. J. Exp. Med. 179:1017-1022.
27. Todorov, A. G., D. Andrade, J. B. Pesquero, R. de C. Araujo, M. Bader, J. Stewart, L. Gera, W. Muller-Esterl, V. Morandi, R. C. Goldenberg, H. C. Neto, and J. Scharfstein. 2003. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J. 17:73-75.
28. Tomas, A. M., and J. M. Kelly. 1996. Stage-regulated expression of cruzipain, the major cysteine protease of Trypanosoma cruzi, is independent of the levels of RNA1. Mol. Biochem. Parasitol. 76:91-103.
29. Tyler, K., and M. A. Miles. 2003. American trypanosomiasis, vol. 7, p. 81-96. Kluwer Academic Publishers, London, United Kingdom.
30. Yoshida, N. 1983. Surface antigens of metacyclic tiypomastigotes of Trypanosoma cruzi. Infect. Immun. 40:836-539.